Detailed Notes on BzATP triethylammonium salt
carbamazepine will lessen the level or outcome of pirfenidone by influencing hepatic enzyme CYP1A2 metabolism. Contraindicated. Utilization of solid CYP1A2 inducers should be discontinued prior to initiating pirfenidone and prevented in the course of remedyUse of robust CYP1A2 inhibitors should be discontinued before initiating therapy and averted